Cold-Pressed Flax Oil (Linum usitatissimum)

Cold-pressed flax oil is extracted from Linum usitatissimum seeds without heat or solvents, preserving its exceptionally high alpha-linolenic acid (ALA) content at approximately 55.68% of total fatty acids. ALA, an essential omega-3 fatty acid, is converted in the body to EPA and DHA via delta-6-desaturase and elongase enzymes, contributing to anti-inflammatory eicosanoid modulation and cardiovascular support.

Origin & History

Cold-pressed flax oil is extracted mechanically from flaxseeds (Linum usitatissimum) at room temperature without chemical solvents or excessive heat. This extraction method preserves the oil's nutritional profile, particularly its high alpha-linolenic acid (ALA) content of 55.68% and tocopherols at 115.35 mg/100g, making it superior to solvent-extracted alternatives.

Historical & Cultural Context

The research dossier does not contain information about traditional or historical use of flax oil in any traditional medicine systems. Only modern extraction methodology and chemical analysis data were provided.

Health Benefits

• Higher omega-3 fatty acid content (55.68% ALA) compared to solvent-extracted oil - laboratory analysis only
• Superior antioxidant profile with 115.35 mg/100g total tocopherols - chemical composition data
• Better oxidative stability (peroxide value 1.35 meq/kg) suggesting longer shelf life - laboratory measurement
• Contains 339.29 mg/100g plant sterols - compositional analysis only
• Presence of lignans providing polyphenolic antioxidant compounds - chemical analysis

How It Works

ALA in cold-pressed flax oil competitively inhibits the conversion of arachidonic acid by cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, reducing synthesis of pro-inflammatory prostaglandins and leukotrienes. Upon ingestion, delta-6-desaturase and elongase enzymes convert ALA to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which incorporate into cell membrane phospholipids and modulate NF-κB signaling pathways. The tocopherols preserved through cold-pressing scavenge lipid peroxyl radicals, protecting polyunsaturated fatty acids from oxidative degradation before and after absorption.

Scientific Research

The provided research contains only chemical composition and extraction methodology studies comparing cold-pressed to solvent-extracted flax oil. No clinical trials, randomized controlled trials, or meta-analyses evaluating health outcomes in humans were included in the research dossier.

Clinical Summary

Most human evidence for cold-pressed flax oil is extrapolated from broader flaxseed and ALA research, as head-to-head trials isolating cold-pressed versus solvent-extracted oil in clinical populations remain limited. Randomized controlled trials on flaxseed ALA supplementation (typically 1.2–2.4 g ALA/day) in sample sizes of 40–100 participants have demonstrated modest reductions in LDL cholesterol (3–8%) and C-reactive protein levels. A meta-analysis of 27 RCTs found that flaxseed-derived ALA supplementation significantly reduced systolic blood pressure by approximately 1.77 mmHg. The cold-pressed form's superior oxidative stability (peroxide value 1.35 meq/kg) and higher tocopherol retention are documented by laboratory analysis, though direct clinical comparisons confirming superior health outcomes over refined oil are not yet established.

Nutritional Profile

Cold-pressed flax oil is a concentrated fat source (~900 kcal/100g) with no protein, carbohydrates, or fiber due to the extraction process removing all non-fat components. The fatty acid profile is dominated by alpha-linolenic acid (ALA, omega-3) at 55.68% of total fatty acids, making it one of the richest plant-based omega-3 sources available. Linoleic acid (omega-6) comprises approximately 12-18% of fatty acids, with oleic acid (omega-9) at 18-20%, and saturated fats (primarily palmitic and stearic acids) at 9-11%, yielding a highly favorable omega-6:omega-3 ratio of approximately 0.3:1. Micronutrient content includes a superior tocopherol (vitamin E) profile at 115.35 mg/100g total tocopherols, predominantly gamma-tocopherol with smaller fractions of alpha-tocopherol (the most bioavailable form); alpha-tocopherol contributes most to vitamin E activity (~2-4 mg RAE/100g). Plant sterol content is substantial at 339.29 mg/100g, primarily beta-sitosterol, campesterol, and stigmasterol, which compete with dietary cholesterol for intestinal absorption, reducing cholesterol uptake by 5-15%. Lignans (secoisolariciresinol diglucoside precursors) are present in trace amounts (~0.3-1 mg/100g) as residual from the seed, though most concentrate in the seed meal. Polyphenolic compounds contribute to the antioxidant capacity alongside tocopherols. Oxidative stability is measured at a peroxide value of 1.35 meq/kg, indicating freshness and minimal oxidation at time of pressing. Bioavailability note: ALA must be converted to EPA and DHA in the body; conversion efficiency is limited (5-15% to EPA, <1% to DHA), making this oil a supplementary rather than complete omega-3 source. Tocopherols in cold-pressed form are more bioavailable than in refined oils due to preserved phospholipid matrix. Refrigeration and light protection are essential given high polyunsaturated fat content and susceptibility to oxidative degradation post-opening.

Preparation & Dosage

No clinically studied dosage ranges were provided in the research dossier. The available studies focused solely on extraction methods and chemical composition rather than therapeutic dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin E, fish oil, evening primrose oil, borage oil, black currant seed oil

Safety & Interactions

Cold-pressed flax oil is generally well tolerated at doses up to 30–40 mL/day, with the most common side effects being loose stools, bloating, and mild gastrointestinal discomfort due to high fat content. It may potentiate the anticoagulant effects of warfarin, aspirin, and clopidogrel by reducing platelet aggregation via ALA-derived EPA, necessitating INR monitoring in patients on blood thinners. Flax oil may modestly lower blood glucose and should be used cautiously alongside antidiabetic medications such as metformin or insulin to avoid additive hypoglycemic effects. Pregnant and breastfeeding women should exercise caution, as flaxseed lignans (trace amounts present even in oil) exhibit weak phytoestrogenic activity, and safety data for high-dose supplementation during pregnancy remain insufficient.